Key result
A pharmacist-guided, patient-driven self-titration protocol for blood pressure medications in a CKD clinic was feasible and resulted in significant improvements in 6-month office systolic and diastolic blood pressure.
Why the study?
Self-titration of blood pressure medications and lifestyle modifications lower blood pressure, but the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling in a chronic kidney disease clinic needed evaluation.
Does a pharmacist-guided, patient-driven self-titration protocol improve blood pressure control in adult patients with CKD and uncontrolled hypertension?
Does a pharmacist-guided, patient-driven self-titration protocol improve blood pressure control in adult patients with CKD and uncontrolled hypertension?
p-value: p=0.32
A pharmacist-guided, patient-driven blood pressure self-titration protocol is feasible, well-received by providers, and associated with improved blood pressure in patients with CKD.
Supports feasibility of pharmacist-guided self-titration in CKD hypertension but should not change practice; leaves open confirmation via randomized trials.
BACKGROUND: Self-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the chronic kidney disease (CKD) clinic. METHODS: Adult patients seen in the CKD clinic were identified via registry screening. Inclusion criteria were as follows: a diagnosis of hypertension, average of the last 3 office BP > 150/90 mmHg, and prescribed 3 or fewer BP medications. Patients with severe hypertension were excluded. BP goals were established and patients were referred to the clinical pharmacist who provided them a BP cuff, a BP medication titration plan (based on home BP monitoring), and dietary education. The following outcomes were evaluated: appeal of the program to patients identified by the registry, patient adherence to the protocol and 6-month office BP, and provider attitudes and acceptance of the protocol. RESULTS: Seventeen patients enrolled in the pilot, the majority recruited via clinic schedule screening. Eleven of the 17 patients completed a 6-month office follow-up visit. Three of the 11 patients met their pre-specified office BP goal. There was, however, significant improvement in 6-month office systolic and diastolic BP. Twelve of 17 patients were adherent to entering home BP in EMR. Provider satisfaction with the protocol was high. CONCLUSION: Our preliminary data suggest that patient-driven self-titration of BP medications is feasible and well received by providers. Future studies are needed to validate these findings and to evaluate the safety and efficacy of this approach.
No takes yet. Share an insight, caveat, or question.
Hopley et al. (2019) studied Chronic Kidney Disease and Hypertension (n=17). Pharmacist-guided patient-driven self-titration of BP medications and dietary counseling was evaluated on Achieving pre-specified office blood pressure goal at 6 months (p=0.32). A pharmacist-guided, patient-driven self-titration protocol for blood pressure medications in a CKD clinic was feasible and resulted in significant improvements in 6-month office systolic and diastolic blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: